Haemonetics Corp. buy BTIG Research
Start price
06.11.25
/
50%
€57.50
Target price
06.11.26
€76.46
Performance (%)
-22.09%
Price
06.05.26
€44.80
Summary
This prediction is currently active. The prediction for Haemonetics Corp. disappoints with a performance of -22.09%. This prediction currently runs until 06.11.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | -12.157% | -12.157% |
| iShares Core DAX® | 0,22 % | 1,81 % |
| iShares Nasdaq 100 | 6,05 % | 15,72 % |
| iShares Nikkei 225® | 5,72 % | 12,34 % |
| iShares S&P 500 | 2,17 % | 7,72 % |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its price target raised by analysts at BTIG Research from $85.00 to $88.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€74.64
06.02.27
06.02.27
-7.44%
06.05.26
06.05.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€72.00
09.01.26
09.01.26
€75.54
09.01.27
09.01.27
-37.78%
06.05.26
06.05.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€67.50
21.11.25
21.11.25
€76.29
21.11.26
21.11.26
-33.63%
06.05.26
06.05.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25